Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(18 sites)
United States
Climb Bio Investigative Site #100104, Allen, Texas Climb Bio Investigative Site #100101, San Antonio, Texas Bulgaria
Climb Bio Investigative Site# 359101, Plovdiv Climb Bio Investigative Site# 359102, Sofia Georgia
Climb Bio Investigative Site #995102, Tbilisi Climb Bio Investigative Site #995101, Tbilisi Greece
Climb Bio Investigative Site# 300102, Exochi, Thessaloniki Climb Bio Investigative Site# 300103, Thessaloniki, Thessaloniki Puerto Rico
Climb Bio Investigative Site #100103, Caguas Romania
Climb Bio Investigative Site# 400101, Cluj-Napoca Spain
Climb Bio Investigative Site# 340101, Sabadell, Barcelona Climb Bio Investigative Site# 340102, A Coruña Ukraine
Climb Bio Investigative Site #380102, Ivano-Frankivsk Climb Bio Investigative Site #380103, Kyiv Climb Bio Investigative Site #380106, Kyiv Climb Bio Investigative Site #380101, Ternopil Climb Bio Investigative Site #380104, Vinnytsia Climb Bio Investigative Site #380105, Vinnytsia